Open Orphan is a growing specialist contract research organisation (CRO) with a high-growth London-based clinical trial business (hVIVO) supported by a European clinical services subsidiary (Venn). High demand for hVIVO's challenge studies in respiratory infections and infectious diseases, helped t

21 Jun 2022
Open Orphan delivering on growth expectations

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Open Orphan delivering on growth expectations
hVIVO plc (HVO:LON) | 20.0 0 0.0% | Mkt Cap: 136.1m
- Published:
21 Jun 2022 -
Author:
Daniel Appiah -
Pages:
7 -
Open Orphan is a growing specialist contract research organisation (CRO) with a high-growth London-based clinical trial business (hVIVO) supported by a European clinical services subsidiary (Venn). High demand for hVIVO's challenge studies in respiratory infections and infectious diseases, helped t